We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+7.01%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$71.6B
AUM Growth
+$8.36B
Cap. Flow
+$5.19B
Cap. Flow %
7.25%
Top 10 Hldgs %
7.9%
Holding
3,652
New
433
Increased
1,585
Reduced
1,146
Closed
462

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$468M
2
JNJ icon
Johnson & Johnson
JNJ
+$440M
3
IBM icon
IBM
IBM
+$355M
4
BKNG icon
Booking.com
BKNG
+$332M
5
RAI
Reynolds American Inc
RAI
+$331M

Sector Composition

Rank Sector Weight
1 Healthcare 15.02%
2 Technology 13.31%
3 Financials 12.25%
4 Industrials 9.65%
5 Consumer Staples 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLWS icon
2626
1-800-Flowers.com
FLWS
$252M
$792K ﹤0.01%
77,600
-2,113
-3% -$21.2K
TLP
2627
DELISTED
Transmontaigne
TLP
$783K ﹤0.01%
17,521
-10,769
-38% -$491K
TTNP
2628
DELISTED
Titan Pharmaceuticals
TTNP
$781K ﹤0.01%
66
+25
+61% +$352K
XNET
2629
Xunlei
XNET
$333M
$780K ﹤0.01%
192,650
-50,250
-21% -$194K
AUPH icon
2630
Aurinia Pharmaceuticals
AUPH
$1.95B
$776K ﹤0.01%
+105,700
New +$488K
IMI
2631
DELISTED
Intermolecular, Inc.
IMI
$773K ﹤0.01%
831,499
+4,633
+0.6% +$4.84K
WEYS icon
2632
Weyco Group
WEYS
$377M
$769K ﹤0.01%
27,400
-2,200
-7% -$61.8K
SGMA
2633
DELISTED
Sigmatron International
SGMA
$767K ﹤0.01%
149,900
+4,000
+3% +$18.1K
RVSB icon
2634
Riverview Bancorp
RVSB
$107M
$764K ﹤0.01%
106,900
+10,600
+11% +$80.1K
CORV
2635
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$763K ﹤0.01%
253,413
+38,400
+18% +$113K
ARCW
2636
DELISTED
ARC Group Worldwide, Inc
ARCW
$762K ﹤0.01%
181,320
+9,506
+6% +$41.6K
IMDZ
2637
DELISTED
Immune Design Corp.
IMDZ
$760K ﹤0.01%
111,740
+70,351
+170% +$407K
LUNA
2638
DELISTED
Luna Innovations Incorporated
LUNA
$755K ﹤0.01%
436,705
+106,500
+32% +$194K
CCLP
2639
DELISTED
CSI Compressco LP
CCLP
$754K ﹤0.01%
76,912
+38,319
+99% +$409K
DSGR icon
2640
Distribution Solutions Group
DSGR
$1.6B
$748K ﹤0.01%
66,600
-43,600
-40% -$543K
CPRX
2641
DELISTED
Catalyst Pharmaceutical
CPRX
$746K ﹤0.01%
+382,400
New +$487K
FWDI
2642
Forward Industries Inc
FWDI
$280M
$746K ﹤0.01%
62,820
+640
+1% +$7.46K
RBCN
2643
DELISTED
Rubicon Technology, Inc.
RBCN
$746K ﹤0.01%
89,600
+6,310
+8% +$37.4K
UBP
2644
DELISTED
Urstadt Biddle Properties Inc.
UBP
$742K ﹤0.01%
43,200
+100
+0.2% +$1.76K
MANT
2645
DELISTED
Mantech International Corp
MANT
$742K ﹤0.01%
21,433
+1,033
+5% +$39.4K
AXIA.PR
2646
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
$741K ﹤0.01%
+107,200
New +$837K
TOUR
2647
Tuniu
TOUR
$56.2M
$741K ﹤0.01%
+8,460
New +$743K
SA
2648
Seabridge Gold
SA
$2.72B
$734K ﹤0.01%
66,700
+15,300
+30% +$159K
NAK
2649
Northern Dynasty Minerals
NAK
$773M
$732K ﹤0.01%
520,100
+288,000
+124% +$592K
SKIS
2650
DELISTED
Peak Resorts, Inc.
SKIS
$732K ﹤0.01%
129,601
+46,801
+57% +$268K

Similar funds

Renaissance Technologies's Q1 2017 Portfolio in Review

As of Q1 2017, Renaissance Technologies held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Renaissance Technologies deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.

  • Renaissance Technologies's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
  • Renaissance Technologies added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
  • Renaissance Technologies's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
  • Renaissance Technologies fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
  • Renaissance Technologies's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
  • Renaissance Technologies opened 433 new positions and closed 462 in Q1 2017.
  • Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $71.6B.

Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.